nasal spray - Search News

Ketamine Nasal Spray Approved

FDA-approved nasal spray for severe depression can lead to remission

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in people who have not responded to at least two oral antidepressants.

Hosted on MSN · 4d

FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult population.

Renal & Urology News · 5h

FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression

(HealthDay News) — The US Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least 2 oral antidepressants, according to a news release issued by Johnson & Johnson.

Alzheimer’s new nasal spray stops memory loss

Revolutionary nasal spray offers hope by potentially delaying Alzheimer's progression through cutting-edge neurological ...

3don MSN

Can a nasal spray cure loneliness? Effects of hormone spritz lasted for months in study

Researchers delivered a dose of the “love hormone” oxytocin via a nasal spray to participants and found that it decreased ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results